Drug Database · Clinicians

Dexketoprofen

Brands (16) Ketesse, Infen-25, Dalyx…Show all

Non-steroidal anti-inflammatory drug (NSAID) and anti-rheumatic; Non-steroidal anti-inflammatory drug (NSAID)/Anti- - rheumatic (propionic acid derivative); and others PH FDA category

Contraindicated if CrCl ≤59Rx · Prescription drug20 PH products Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Contraindications

  • CrCl 59 mL/min or less
  • History of NSAID-related gastrointestinal bleeding, perforation or ulcer; active peptic ulcer
  • Severe heart failure
  • Severe hepatic impairment (Child-Pugh 10–15)
  • Bleeding disorders; inflammatory bowel disease
  • Severe dehydration
  • Third trimester of pregnancy; breastfeeding
  • NSAID hypersensitivity (asthma, urticaria)
renalcarematters.com, reviewed

Dosing: Adult

  • Acute mild to moderate pain (adults): 25 mg every 8 hours; maximum 75 mg/day; shortest duration
  • Older adults, mild–moderate hepatic impairment, CrCl 60–89: Start at 50 mg/day total
  • Acute moderate to severe pain, injection (IV or IM): 50 mg every 8 to 12 hours (may repeat after 6 hours if needed); maximum 150 mg/day; no more than 2 days. CrCl 60–89: 50 mg/day total; CrCl ≤59: contraindicated
renalcarematters.com, reviewed

Dosing: Altered kidney function

Dexketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) excreted mainly in urine as glucuronide. NSAIDs can cause fluid retention, hyperkalemia and acute kidney injury. The Irish label starts at 50 mg/day in mild kidney impairment (creatinine clearance [CrCl] 60–89 mL/min) and contraindicates it at CrCl 59 mL/min or below. It has no US FDA label.

Kidney function measure: Irish summary of product characteristics (SmPC) uses creatinine clearance (CrCl, mL/min); thresholds 89 and 59.

Show full dosing details
CrCl ≥60 mL/min
CrCl ≥90: 25 mg every 8 hours, maximum 75 mg/day, shortest course. CrCl 60–89: start at 50 mg/day total (SmPC). Injection: 50 mg every 8 to 12 hours, maximum 150 mg/day, no more than 2 days; CrCl 60–89: 50 mg/day total (injection SmPC).
CrCl 30–59 mL/min
Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
CrCl 15–29 mL/min
Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
CrCl <15 mL/min (not on dialysis)
Contraindicated: moderate to severe kidney dysfunction (CrCl ≤59 mL/min) (oral and injection SmPCs).
Hemodialysis (intermittent)
Contraindicated (CrCl ≤59; SmPC).
Peritoneal dialysis
Contraindicated (CrCl ≤59; SmPC). NSAIDs also hasten loss of residual kidney function.
CRRT
Contraindicated (CrCl ≤59; SmPC); NSAIDs worsen acute kidney injury.
  • Dialyzable? Not stated (99% protein-bound).
  • Monitoring Kidney function, potassium and fluid status, especially with diuretics, ACE inhibitors, ARBs or volume depletion; keep the patient hydrated. Gastrointestinal bleeding. Shortest course (SmPC 4.4).
Children (kidney dosing)
eGFR ≥60
Not established in children; kidney dosing not applicable.
eGFR 30–59
Not established in children; kidney dosing not applicable.
eGFR 15–29
Not established in children; kidney dosing not applicable.
eGFR <15 (not on dialysis)
Not established in children; kidney dosing not applicable.
Hemodialysis (intermittent)
Not established in children; kidney dosing not applicable.
Peritoneal dialysis
Not established in children; kidney dosing not applicable.
CRRT
Not established in children; kidney dosing not applicable.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

Source: HPRA (Ireland) product information (April 2023). This generic has no US FDA label.

Dosing: Pediatric

Approved ages
Not to be used in children and adolescents (SmPC).
Usual dose
Not established.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed

Dosage forms

Philippines

  • Film-coated tablet: 25 mg
  • ) solution for injection: 25 mg/mL (50 mg/2 mL
  • Solution for injection: 25 mg/mL
  • Tablet: 25 mg
  • ) solution for injection or concentrate for infusion: 25 mg/mL (50 mg/2 mL
  • Granule for oral solution: 25 mg

Registered products in the Philippines

20 products registered with the Food and Drug Administration (FDA) Philippines list Dexketoprofen as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products20
Philippine FDA-registered products for Dexketoprofen
Package insert
DalyxDexketoprofen (as trometamol)
50 mg/2 mL Solution For Injection or Concentrate For Solution For Infusion (IV/IM)Type I amber glass ampoule with break ring x 2 mL (Box of 5's)
Rx
Rompharm Company SRLRomania
The Cathay Drug Co., Inc.Importer: I.E. Medica, Inc.
DR-XY46849
Mar 11, 2031
DeccetrolDexketoprofen (As Trometamol)
25mg/mL Solution For Injection (IM/IV)Type I amber ampoule x 2 mL (Box of 6's)
Rx
Osel Ilac San Ve Tic A.S.Turkey
Accesspoint International Trading Inc.Importer: Accesspoint International Trading, Inc.
DRP-14214
Jul 27, 2028
DexoflamDexketoprofen (as trometamol)
25 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's, 30's & 100's)
Rx
Ratnatris Pharmaceuticals Pvt. Ltd.India
Medinova Pharmaceutical Inc.
DRP-17814
Mar 12, 2031
DexomolDexketoprofen (as trometamol)
25 mg Film-Coated TabletOpaque White PVC/PE/PVDC Aluminum Foil Blister Pack x 10's (Box 20's)
Rx
Santa Farma İlaç Sanayii A.Ş.Turkey
Orange Biotec Inc.
DRP-15704
Aug 29, 2029
DexprokenDexketoprofen (as Trometamol)
25 mg/mL (50 mg/2 mL) Solution For Injection (IM/IV)2 mL USP Type I amber glass ampoule (Box of 6's)
Rx
İdol İlaç Dolum San. Ve Tic. A.Ş.Turkey
Importer: Ambicare Pharmaceuticals, Inc.Trader: Helba İlaç Ic ve Dis Sa. Tic. A.Ş.
DRP-13850
May 5, 2028
DitroxDexketoprofen (as trometamol)
25 mg/mL (50 mg/2 mL) Solution for Injection (I.M./I.V.)USP Type 1 amber glass ampoule x 2 mL (Box of 10's)
Rx
Ratnatris Pharmaceuticals Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-17118
Oct 1, 2030
ElpidexDexketoprofen (as trometamol)
25 mg / mL Solution for Injection (IM/IV)Type I amber ampoule x 2 mL (Box of 6's)
Rx
Osel Ilac San. Ve Tic. A.S.Turkey
Elpizo Holdings IncImporter: Accesspoint International Trading Inc.
DRP-14214-01
Jul 27, 2028
Infen-25Dexketoprofen (as trometamol)
25 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
Rx
Emcure Pharmaceuticals LimitedIndia
Emcure Pharma Philippines Inc.
DR-XY45922
Jun 14, 2027
Infen-25Dexketoprofen (as trometamol)
25mg Film -Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
Rx
Emcure Pharmaceuticals LimitedIndia
Emcure Pharma Philippines Inc.
DRP-16550
Jun 14, 2027
KeprofynDexketoprofen (as trometamol)
25 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's)
Rx
Globela Pharma Private LimitedIndia
AMB HK Enterprises Inc.
DRP-14656
Nov 17, 2028
KeralDexketoprofen (as trometamol)
25 mg/mL (50 mg/2 mL) Solution for Injection or Concentrate for Solution for Infusion (I.M./I.V.)2 mL Type I Amber Glass Ampoule (Box of 1’s and 5’s)
Rx
A. Menarini Manufacturing Logistics and Services SRLItaly
A. Menarini Philippines, Inc.
DR-XY36227
Jul 13, 2029
KetesseDexketoprofen (as trometamol)
25 mg Granules for Oral Solution2.5 g sachet (aluminum-polyethylene) Box of 4's, 10's and 20's
Rx
Laboratorios Menarini, SASpain
A. Menarini Philippines, Inc.Trader: A. Menarini Asia-Pacific Holdings Pte. Ltd.
DR-XY46140
Nov 9, 2027
KetesseDexketoprofen (as Trometamol)
25mg Film-Coated TabletAlu/Alu (PA/Aluminum/PVC/Aluminum) Blister Pack x 10's (Box of 20's)
Rx
A. Menarini Manufacturing Logistics and Services S.R.L.Italy
Importer: A. Menarini Philippines, Inc.
DR-XY36275
May 29, 2027
KetesseDexketoprofen (as trometamol)
25mg/mL (50mg/2mL) Solution for Injection or Concentrate for Infusion (I.M./I.V)2 mL Type I Amber glass ampoule (Box of 1’s); 2 mL Type I Amber glass ampoule (Box of 5’s)
Rx
A. Manerini Manufacturing Logistics and Services S.R.L.Italy
A.MENARINI PHILIPPINES, INC
DR-XY36266
Jul 17, 2029
KetofenaxDexketoprofen (as trometamol)
50mg/2mL Solution for Injection or Concentrate for Solution for Infusion (I.V./I.M.)Type I Amber Glass Ampoule with Break Ring x 2 mL (Box of 5's and 10's)
Rx
S.c Rompharm Company S.R.L.Romania
I.E. Medica, Inc.
DR-XY46848
Mar 11, 2027
KeviaDexketoprofen
25 mg/mL (50 mg/2 mL) Solution for Injection or Concentrate for Solution for Infusion (I.M./I.V.)USP Type I Amber Coloured Glass Ampoule x 2 mL (Box of 1’s, 5’s and 10’s)
Rx
Ciron Drugs & Pharmaceuticals Pvt. Ltd.India
Despina Pharma Inc.
DRP-18941
Oct 5, 2031
MetademDexketoprofen Trometamol
25 mg/mL (50 mg/2 mL) Solution for Injection (IM/IV)2 mL Type I amber colored Glass ampoules (Box of 6's)
Rx
VEM Ilac San. Ve Tic A.S.Turkey
Macropharma Corparation
DRP-14332
Aug 22, 2028
ProfiemDexketoprofen (as Trometamol)
25 mg TabletAlu-Alu Blister pack x 10's (Box of 20's)
Rx
Novagen Healthcare Private LimitedIndia
I.E Medica, Inc.
DRP-15811
Sep 17, 2029
VoxibDexketoprofen (as trometamol)
25 mg/ml Solution for Injection (1. M./1.V.) or Concentrate for Solution for I. V. Infusion2 mL (net content) Ph. Eur. Type I amber glass ampoule X 5 ampoules in transparent PVC tray (Box of 5 ampoules)
Rx
PT. Novell Pharmaceutical LaboratoriesIndonesia
Prosweal Healthcare, Inc.
DR-XY48077
Jun 1, 2027
(no brand name)Dexketoprofen (as Trometamol)
25 mg TabletAlu-Alu Blister pack x 10's (Box of 20's)
Rx
Novagen Healthcare Private LimitedIndia
I.E Medica, Inc.
DRP-15812
Sep 17, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Drug interactions

Drug or classSeverityEffectWhat to do
Other NSAIDs, COX-2 inhibitors, salicylates 3 g/day or moreAvoidMore gastrointestinal ulceration and bleeding.Do not combine.
Warfarin, heparinsAdjust or monitorMore bleeding.Avoid if possible; otherwise monitor closely.
Diuretics, ACE inhibitors, ARBs, aminoglycosidesAdjust or monitorLess blood-pressure effect; kidney deterioration.Hydrate; monitor kidney function.
Potassium-sparing diureticsAdjust or monitorHyperkalemia.Monitor potassium.
MethotrexateAvoidHematologic toxicity.Avoid at 15 mg/week or more; weekly blood counts at lower doses.
LithiumAdjust or monitorHigher lithium levels.Monitor lithium.
Corticosteroids, SSRIs, antiplateletsAdjust or monitorMore gastrointestinal bleeding.Use with caution.
Tenofovir, zidovudine, pemetrexedAdjust or monitorNephrotoxicity (tenofovir); anemia (zidovudine); pemetrexed toxicity.Monitor kidney function or blood counts; avoid around pemetrexed doses.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed

Adverse reactions

Common

  • Nausea, vomiting
  • Abdominal pain, diarrhea, dyspepsia

Serious

  • Peptic ulcer, gastrointestinal bleeding or perforation
  • Acute kidney failure, nephritis, nephrotic syndrome
  • Anaphylaxis
  • Stevens-Johnson syndrome, toxic epidermal necrolysis
  • Neutropenia, thrombocytopenia
renalcarematters.com, reviewed

Monitoring parameters

  • Kidney function, potassium and fluid status, especially with diuretics, ACE inhibitors, ARBs or volume depletion; keep the patient hydrated. Gastrointestinal bleeding. Shortest course (SmPC 4.4). Kidney
  • Kidney function, potassium and blood pressure in at-risk patients
  • Gastrointestinal bleeding
renalcarematters.com, reviewed

Pharmacokinetics

Key PK parameters

Time to peak15 to 20 minutes (oral solution)
Half-life1.65 hours
Volume of distributionUnder 0.25 L/kg
Protein binding99%
Metabolism (CYP, transporters)Glucuronide conjugation (no inversion to R-enantiomer)
Renal excretion kidneyMainly renal as glucuronide (percentage not stated)
Dialyzability kidneyNot stated
renalcarematters.com, reviewed

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Health Products Regulatory Authority (Ireland). Keral 25 mg oral solution in sachet SmPC (PA0865/002/006) [HPRA (Ireland) product information, April 2023; no US FDA label]. https://assets.hpra.ie/products/Human/22403/Licence_PA0865-002-006_05042023153747.pdf
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. Menarini International Operations Luxembourg S.A.. (2023). Keral 25 mg oral solution in sachet (dexketoprofen) [Summary of product characteristics, licence PA0865/002/006; text revised April 2023]. Health Products Regulatory Authority (Ireland). https://assets.hpra.ie/products/Human/22403/Licence_PA0865-002-006_05042023153747.pdf
  4. AS Kalceks. (2026). Morsadex 50 mg/2 mL solution for injection/infusion (dexketoprofen) [Summary of product characteristics, licence PA2165/002/001; text revised May 2026]. Health Products Regulatory Authority (Ireland). https://assets.hpra.ie/products/Human/30409/Licence_PA2165-002-001_06052026140647.pdf

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .